Literature DB >> 21695442

Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection.

R Greenberg1, R Itah, R Ghinea, E Sacham-Shmueli, R Inbar, S Avital.   

Abstract

BACKGROUND: Lymph node ratio (LNR: the ratio of metastatic to total retrieved nodes) has shown prognostic significance in several tumors. Its role in patients with colorectal cancer submitted to laparoscopic resection is still not clearly defined. The aim of this study was to evaluate the impact of LNR on long-term outcome in patients undergoing curative laparoscopic resection.
METHODS: Patients' data were retrieved from our prospective in-hospital collected data of patients that underwent laparoscopic surgery for curable colorectal cancer over a 6-year period. Long-term data were collected from our outpatient's clinic data and personal contact when necessary.
RESULTS: Two hundred and five patients underwent laparoscopic resection for curable colorectal cancer in the study period. Sixty-five patients were node positive. Receiver operating characteristic (ROC) analysis selected 0.13 as the best LNR cutoff value in this group. Kaplan-Meier 5-year survival analysis revealed a significant decrease in overall and disease-free survival in patients with an LNR above 0.13. Long-term outcome of patients with an LNR below 0.13 was similar to node-negative stage II patients.
CONCLUSIONS: The lymph node ratio is a valuable prognostic factor in node-positive colon cancer patients undergoing laparoscopic resection. Patients with an LNR below 0.13 have the same long-term outcome as stage II node-negative patients. The laparoscopic approach presents the same trends in terms of overall survival and disease-free survival as conventional open access when LNR is considered.

Entities:  

Mesh:

Year:  2011        PMID: 21695442     DOI: 10.1007/s10151-011-0701-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  27 in total

1.  The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.

Authors:  N Y Haboubi; P Clark; S M Kaftan; P F Schofield
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

2.  Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

3.  The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery.

Authors:  Gennaro Galizia; Michele Orditura; Francesca Ferraraccio; Paolo Castellano; Margherita Pinto; Anna Zamboli; Sabrina Cecere; Ferdinando De Vita; Carlo Pignatelli; Eva Lieto
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

4.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

5.  Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.

Authors:  James Fleshman; Daniel J Sargent; Erin Green; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; Heidi Nelson
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

6.  Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer.

Authors:  Luciano José Megale Costa; Heloisa Prado Soares; Heloisa Amaral Gaspar; Luciana Garcia Trujillo; Patrícia Xavier Santi; Rafaela Sarmento Pereira; Thaís Lins de Santana; Fernanda Nunes Pinto; Auro del Giglio
Journal:  Am J Clin Oncol       Date:  2004-06       Impact factor: 2.339

7.  Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer.

Authors:  Chih-Chien Chin; Jeng-Yi Wang; Chien-Yuh Yeh; Yi-Hung Kuo; Wen-Shih Huang; Chung-Hung Yeh
Journal:  Int J Colorectal Dis       Date:  2009-05-29       Impact factor: 2.571

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens.

Authors:  Michelle A Ostadi; Julie L Harnish; Stacey Stegienko; David R Urbach
Journal:  Surg Endosc       Date:  2007-05-24       Impact factor: 4.584

10.  Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.

Authors:  David G Jayne; Pierre J Guillou; Helen Thorpe; Philip Quirke; Joanne Copeland; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

View more
  11 in total

1.  Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.

Authors:  Marianne Huebner; Michael Kendrick; Kaye M Reid-Lombardo; Florencia Que; Terry Therneau; Rui Qin; John Donohue; David Nagorney; Michael Farnell; Michael Sarr
Journal:  J Gastrointest Surg       Date:  2012-03-16       Impact factor: 3.452

Review 2.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all.

Authors:  M Medani; Niall Kelly; George Samaha; G Duff; Vourneen Healy; Elizabeth Mulcahy; Eoghan Condon; David Waldron; Jean Saunders; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2013-05-29       Impact factor: 2.571

4.  Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

Authors:  Upali W Jayasinghe; Nirmala Pathmanathan; Elisabeth Elder; John Boyages
Journal:  Springerplus       Date:  2015-03-11

5.  Laparoscopic surgery for locally advanced T4 colon cancer: the long-term outcomes and prognostic factors.

Authors:  Takahiro Yamanashi; Takatoshi Nakamura; Takeo Sato; Masanori Naito; Hirohisa Miura; Atsuko Tsutsui; Masashi Shimazu; Masahiko Watanabe
Journal:  Surg Today       Date:  2017-12-29       Impact factor: 2.549

6.  Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.

Authors:  Ming-Ran Zhang; Tian-Hang Xie; Jun-Lin Chi; Yuan Li; Lie Yang; Yong-Yang Yu; Xiao-Feng Sun; Zong-Guang Zhou
Journal:  Oncotarget       Date:  2016-11-08

7.  The prognostic significance of lymph node size in node-positive colon cancer.

Authors:  Philipp Schrembs; Benedikt Martin; Matthias Anthuber; Gerhard Schenkirsch; Bruno Märkl
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

8.  Metastatic Lymph Node Ratio (mLNR) is a Useful Parameter in the Prognosis of Colorectal Cancer; A Meta-Analysis for the Prognostic Role of mLNR.

Authors:  Jung Soo Pyo; Joo Heon Kim; Seung Yun Lee; Tae Hwa Baek; Dong Wook Kang
Journal:  Medicina (Kaunas)       Date:  2019-10-04       Impact factor: 2.430

9.  Prognostic Implication of Metastatic Lymph Node Ratio in Colorectal Cancers: Comparison Depending on Tumor Location.

Authors:  Jung-Soo Pyo; Young-Min Shin; Dong-Wook Kang
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

10.  Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers.

Authors:  Junjie Peng; Ying Ding; Shanshan Tu; Debing Shi; Liang Sun; Xinxiang Li; Hongbin Wu; Sanjun Cai
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.